Incyte Gains Exclusive Global Development And Commercialization Rights To Tafasitamab (Monjuvi) Read more
AQEMIA Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline Read more
Regeneron Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio Platforms and Preclinical and Clinical Programs Read more
Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain Read more
GSK’s RSV vaccine, Arexvy, accepted for regulatory review by the European Medicines Agency for the prevention of RSV disease in adults aged 50-59 at increased risk Read more
Takeda’s GAMMAGARD LIQUID Approved by FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Read more
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours Read more
Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations Read more